Testing the Addition of Radiation Therapy to Immunotherapy for Merkel Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Pembrolizumab
Related studies linked through entity extraction aliases.
Study of Pembrolizumab Given With Ipilimumab or Placebo in Participants With Untreated Metastatic Non-Small Cell Lung Cancer (NSCLC) (MK-3475-598/KEYNOTE-598)
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Indoximod or Placebo Plus Pembrolizumab or Nivolumab for Subjects With Unresectable or Metastatic Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
Pembrolizumab and Trametinib in Treating Patients With Stage IV Non-Small Cell Lung Cancer and KRAS Gene Mutations
- Status
- COMPLETED
- Phase
- PHASE1
Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Pembrolizumab in Elderly Patients With Advanced Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase 0- Pilot Study of Pembrolizumab on Immune Cells in Patient With Refractory Acute Myeloid Leukemia
- Status
- WITHDRAWN
- Phase
- EARLY_PHASE1
Epacadostat and Pembrolizumab in Patients With GIST
- Status
- TERMINATED
- Phase
- PHASE2
Phase II Study of Pembrolizumab and Lenvatinib in Advanced Well-differentiated Neuroendocrine Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Neoadjuvant Pembrolizumab(Pbr)/Nab-Paclitaxel Followed by Pbr/Epirubicin/Cyclophosphamide in TNBC
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Anti-PD(L)1 and SBRT in the Treatment of Advanced, Platinum-Refractory Urothelial Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Augmentation of the Graft vs. Leukemia Effect Via Checkpoint Blockade With Pembrolizumab
- Status
- TERMINATED
- Phase
- PHASE1
Study of Pembrolizumab (MK-3475) in Adults With Recurrent/Metastatic Cutaneous Squamous Cell Carcinoma (cSCC) or Locally Advanced Unresectable cSCC (MK-3475-629/KEYNOTE-629)
- Status
- COMPLETED
- Phase
- PHASE2
Combination of Pembrolizumab With TGR-1202 in Patients With Relapsed/Refractory CLL and B-cell NHL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Phase II Trial of Pembrolizumab in Recurrent or Residual High Grade Meningioma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Pembrolizumab (MK-3475) in Combination With Romidepsin
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
INCAGN01876 in Combination With Immune Therapies in Subjects With Advanced or Metastatic Malignancies
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Imiquimod and Pembrolizumab in Treating Patients With Stage IIIB-IV Melanoma
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Pembrolizumab in Combination With Doxorubicin in Advanced, Recurrent or Metastatic Endometrial Cancer
- Status
- COMPLETED
- Phase
- PHASE2